XellSmart Biomedical

XellSmart Biomedical (士泽生物医药) is a clinical-stage biotechnology company based in Suzhou and Shanghai, China, founded in 2021 by Dr. Xiang Li. The company develops clinical-grade, allogeneic, off-the-shelf iPSC-derived cell therapies for central nervous system diseases, with NMPA- and U.S. FDA-cleared registrational clinical trials in Parkinson's disease, spinal cord injury, and ALS. XellSmart is a Qiming Venture Partners portfolio company and publishes no public developer or API surface.

XellSmart Biomedical is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Cell Therapy, Regenerative Medicine, and Neuroscience.

XellSmart Biomedical’s developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyCell TherapyRegenerative MedicineNeuroscienceHealthcareChina

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.2/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/xellsmart: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: xellsmart
name: XellSmart Biomedical
description: XellSmart Biomedical (士泽生物医药) is a clinical-stage biotechnology company based in Suzhou and Shanghai, China,
  founded in 2021 by Dr. Xiang Li. The company develops clinical-grade, allogeneic, off-the-shelf iPSC-derived cell therapies
  for central nervous system diseases, with NMPA- and U.S. FDA-cleared registrational clinical trials in Parkinson's disease,
  spinal cord injury, and ALS. XellSmart is a Qiming Venture Partners portfolio company and publishes no public developer
  or API surface.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.xellsmart.com/uploads/allimg/20250904/c41dd315cd97651c5b84601ec1ac3783.svg
url: https://raw.githubusercontent.com/api-evangelist/xellsmart/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Cell Therapy
- Regenerative Medicine
- Neuroscience
- Healthcare
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/xellsmart-domain-security.yml
- type: Website
  url: https://www.xellsmart.com
- type: Blog
  url: https://www.xellsmart.com/gsxw.html
- type: PrivacyPolicy
  url: https://www.xellsmart.com/privacy.html
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1

XellSmart Biomedical

Kin Score

Security Posture 1

Xellsmart Domain Security

Resources

Access & Security 1

Commercial 1

Company 2

Source (apis.yml)